There has been a lot of M&A activity happening in the CRO sector this year, specifically, unions between CROs and clinical tech shops. In an effort to provide clinical trial services and solutions from soup to nuts, CROs that previously did not have an eClinical solution are turning to technology firms to fill in the gaps.
But trying to migrate from paper-based clinical research processes to technology-based tools such as electronic data capture and clinical trial management layered on top of existing (and often inefficient) methods presents some challenges. Integrating assets, disparate IT and operating systems, and dealing with legacy data and infrastructure is not only time-consuming, but also a drain on resources. The independent systems and software make cross-talk among functions difficult and integration among functions expensive.
The end result is widespread duplication of effort and frequent miscommunication. And any sort of slowdown or silos in current processes could see customers deciding to go elsewhere.
Clinipace Worldwide had a glimpse into the future and built its business with these challenges in mind, proactively meeting them head-on with our technology-amplified service model.
Our digital CRO (dCRO) model is characterized by a unified technology framework that enables integration, collaboration, and transparency across all stakeholders: integration and collaboration among functions and roles across the spectrum of clinical trials activities (e.g., Site Selection/Management, Patient Recruitment, Project Management, Monitoring, Data Management, Biostatistics) and project and stakeholder-wide transparency of both clinical research processes and clinical trial metadata.
In our proactive efforts, integration and transparency foster an unprecedented level of information sharing, enable efficient information analysis for better decision-making, risk management, and cost predictability.
With the traditional Contract Research Organization (CRO) model, eClinical technology is an add-on that typically adds to trial complexity and cost, as there is an increase in “friction” points. Clinipace, via its dCRO model, has flipped establish manual-based processes on their head. People are added to technology-amplified processes that aim to integrate systems, while reducing the coefficient of friction so trials run with less complexity and cost. With judiciously employed technology, fewer people and resources are needed to do a job. In the dCRO, technology carries some of the work burden that would typically be carried by people, so the people component is smaller and less expensive.
Beginning with the end in mind will hopefully make for a happy, life-long relationship.